|
Market Cap (17-May) $82,472,520 (825th) |
Close (30-Jun) $1.50 |
Volume (30-Jun) 19,997 |
Shortsold (12-Dec) 1,378 (0.00%) (711th) |
|
52w High $1.33 |
52w Low $1.10 |
P/E - |
EPS - |
CD3 released this announcement to the ASX on 7 October 2022, 17:38. The announcement is not marked as price sensitive, and is 80 page(s) in length and 1.09MB in size.
You can view all announcements from CD3 and see how they appear on a price chart on the announcements page.
At the date of this announcement, CD3 was 0.002% short sold according to ASIC data. It was ranked the 711th most shorted stock on the ASX. It remains ranked 711th as of the latest reported data (12 December 2022).
| Other Recent Announcements from CD3 | |
|---|---|
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:27 |
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:25 |
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:22 |
| Product Disclosure Statement | 7 October 2022, 17:38 |
| Explanatory Memorandum | 7 October 2022, 17:17 |
| Merger Proposal - Explanatory Memorandum & Notice of Meeting | 7 October 2022, 17:08 |
| Merger Proposal - CD Private Equity Fund Series | 5 October 2022, 9:49 |
You must be logged in to post a reply.
